Prostate-specific antigen (PSA) screening rates decreased during the COVID-19 pandemic among Black and White men. Although rates recovered two years later, Black men had a slower recovery, according to a study presented at the 25th Annual Meeting of the Society of Urologic Oncology. A weighted total of more than 1.3 million men, aged 45 to75 years, was analyzed using data from the Behavioral Risk Factor Surveillance System surveys conducted in 2018, 2020, and 2022. PSA screening incidence within two years before each survey was the primary outcome. ...